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ABSTRACT
Pre-pregnancy obesity is an established risk factor for adverse sex-specific cardiometabolic health
in offspring. Epigenetic alterations, such as in DNA methylation (DNAm), are a hypothesized link;
however, sex-specific epigenomic targets remain unclear. Leveraging data from the Newborn
Epigenetics Study (NEST) cohort, linear regression models were used to identify CpG sites in cord
blood leukocytes associated with pre-pregnancy obesity in 187 mother-female and 173 mother-
male offsprings. DNAm in cord blood was measured using the Illumina HumanMethylation450k
BeadChip. Replication analysis was conducted among the Avon Longitudinal Study of Parents and
Children (ALSPAC) cohort. Associations between pre-pregnancy obesity-associated CpG sites and
offspring BMI z-score (BMIz) and blood pressure (BP) percentiles at 4–5-years of age were also
examined. Maternal pre-pregnacy obesity was associated with 876 CpGs in female and 293 CpGs
in male offspring (false discovery rate <5%). Among female offspring, 57 CpG sites, including the
top 18, mapped to the TAPBP gene (range of effect estimates: −0.83% decrease to 4.02% increase
in methylation). CpG methylation differences in the TAPBP gene were also observed among males
(range of effect estimates: −0.30% decrease to 2.59% increase in methylation). While technically
validated, none of the TAPBP CpG sites were replicated in ALSPAC. In NEST, methylation differ-
ences at CpG sites of the TAPBP gene were associated with BMI z-score (cg23922433 and
cg17621507) and systolic BP percentile (cg06230948) in female and systolic (cg06230948) and
diastolic (cg03780271) BP percentile in male offspring. Together, these findings suggest sex-
specific effects, which, if causal, may explain observed sex-specific effects of maternal obesity.
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More than 9% of preschool-aged children 2–5
years of age are classified as obese, as are 18% of
children ages 6–11 years and 21% of 12–19 years
of age in the U.S [1]. Although the prevalence of
childhood obesity may be plateauing, the preva-
lence in males and ethnic minorities continues to
increase [2]. Childhood obesity is associated with
higher blood pressure (BP), recurrent wheezing,
and metabolic disease, which are consistent risk
factors for common chronic diseases and condi-
tions in later life, including type 2 diabetes, cor-
onary heart disease, some cancers, and life-long
obesity [3–10].
Data from the last 15 years have demonstrated
that the first 1,000 days, the period from conception
to two years of age, represents a critical developmen-
tal window in which exposures can play a major role
in the programming of physiological systems
involved in growth, energy metabolism, adipogen-
esis, appetite and glucose-insulin homeostasis of the
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developing offspring [11]. Both pre-pregnancy obe-
sity and excessive gestational weight gain (GWG)
independently contribute to cardiometabolic func-
tion, including obesity, in offspring [3–5]. With 25%
of conceptions occurring among obese women in the
U.S [12]., maternal obesity before and during preg-
nancy is perhaps one of the most common intrau-
terine risk factors for childhood obesity for which we
have limited mechanistic insights.
While mechanisms by which maternal obesity is
linked to childhood obesity are still unclear, mount-
ing evidence from animal and human studies sup-
ports that a wide range of in utero exposures [10,13–
17], including pre-pregnancy obesity and gestational
weight gain [18–22], are associated with epigenetic
modifications, including DNA methylation of cyto-
sine-phosphate-guanine (CpG) sites, which can in
turn alter the transcriptional capacity of genes
important in metabolism. A recent meta-analysis
comprising 19 studies with >9,000 participants with
DNAmethylation measured in umbilical cord blood
leukocytes using CpG methylation arrays identified
86 maternal obesity-associated CpG sites; however,
there was no evidence of enrichment for chromoso-
mal regions or disease pathways [19]. In addition,
sex-specific data relating maternal obesity to CpG
methylation is lacking and limited research exists
with follow-up into childhood to estimate the impact
of pre-pregnancy related CpG methylation on cardi-
ometabolic health [18]. To fill this gap, we conducted
an epigenome-wide association analysis to deter-
mine whether associations between maternal pre-
pregnancy obesity and CpG methylation, measured
in umbilical cord blood leukocytes, varied by off-
spring sex, and whether maternal pre-pregnancy
obesity-associated CpG methylation was associated
with offspring cardiometabolic phenotypes, body
mass index (BMI) and BP at 4–5 years of age.
Results
The distribution of maternal and offspring char-
acteristics for 360 mother-offspring pairs are sum-
marized in Table 1. African-American women
comprised almost half (48%) of the NEST study
sample. Participating women were approximately
25 years of age and older (72%), educated beyond
high school (70%), and reported not smoking
during pregnancy (68%). Approximately 48% had
a pre-pregnancy BMI less than 25kg/m2, 21% were
overweight (BMI 25–29.99 kg/m2), and 31% were
obese (BMI ≥30 kg/m2). Among the obese, 12%
were Class III obese (≥40kg/m2).
Pre-pregnancy obesity and CpG methylation
Among female offspring, pre-pregnancy obesity was
associated with differential methylation at 6,148
CpG sites (FDR <0.05; Supplemental Table 1), cor-
responding to 1,034 genes. Adjustment for cell pro-
portion reduced the number of significant CpG sites
to 876 corresponding to 101 genes (Supplemental
Table 2; Figure 1). Among male offspring at birth,
781 CpG sites were associated with pre-pregnancy
obesity (FDR <0.05); Supplemental Table 3).
Adjustment for estimated cell proportions reduced
the number of significant CpG sites to 293 corre-
sponding to 31 genes (Supplemental Table 4; Figure
2). After adjusting for cell type estimates, lambdas
(λ) were close to one for the mother-female offspring
model (λ = 0.95) and mother-male offspring models
(0.78). In a sensitivity analysis, we examined the
association between maternal pre-pregnancy obesity
and cell type proportions, where we observed signif-
icant positive associations among female offspring
(Supplemental Table 5). Specifically, maternal obe-
sity was associated with increased CD4+T-cells,
B-cells, and granulocytes. We did not observe any
associations in male offspring.
Table 2 provides the top 20 genes with the most
robust methylation differences for female offspring
of obese and non-obese pregnant women before and
after adjusting for cell proportions. After adjustment
for cell proportion, the most robust methylation
differences that were associated with maternal obe-
sity corresponded to TAPBP (57 CpGs), RP11 (13
CpGs),NFE2L3 (6 CpGs),GLIPR1L2 (11 CpGs), and
MFSD1 (10 CpGs). Of the 57 CpG sites annotated to
the TAPBP gene, 48 were associated with higher
offspring methylation (range of effect estimates:
0.83% to 4.02% increase in methylation; range of
associated p-values: 1.31 × 10−10 to 1.61 × 10−12).
Table 3 summarizes the 20 genes with the most
robust methylation differences among male off-
spring of obese versus non-obese pregnant women.
Prior to adjustment for cell proportion, the most
robust differences were at CpG sites in or near GFI1
(9 CpGs), HOXA3 (15 CpGs), and WDFY4 (17
CpGs). After adjustment for cell proportion, robust
differences remained at CpG sites in or near GFI1
(10 CpGs). Notably, CpG methylation differences in
the TAPBP gene (17 CpGs) were also observed
among male offspring. Of the 17 CpG sites that
mapped to the TAPBP gene, 15 were associated
with higher methylation; however, the magnitude
of male-specific associations was smaller than those
for female offspring (range of effect estimates: 0.79%
to 2.59%; range of associated p-values: 5.57 × 10−3 to
6.07x10−3; Supplemental Table 2).
Validation study
To determine whether findings identified using
the Illumina HumanMethylation450k BeadChip
(HM450k) array could be replicated in an inde-
pendent dataset within the same cohort, we used
more accurate pyrosequencing to quantify methy-
lation at the TAPBP gene among male and female
offspring born to obese (n = 20) and non-obese
women (n = 24). We found that the CpG sites that
flanked and included cg14419102 in TAPBP gene
had ~2% higher methylation in offspring of obese
women when compared to non-obese women (vs.
3% from the array). The relationship between pre-
pregnancy obesity and higher methylation per-
sisted at 311 bp chr6:28,943,509–28,943,820 region
in female offspring at sequence regions flanking
cg18353226 and cg06375761 near TAPBP, where
significant methylation differences were the least
robust (<2%), chr6:33,312,579–33,312,730.
Replication study – ALSPAC
HM450K methylation array data from 751
mother-offspring pairs in the Avon Longitudinal
Study of Parents and Children (ALSPAC) cohort
from Bristol, UK was used as our replication data-
set. Prior to multiple testing correction, maternal
pre-pregnancy obesity was associated with differ-
ential methylation at 10 CpGs of TAPBP gene
among female offspring and at 12 CpGs of the
same gene among males after adjusting for cell
proportion. Among the 10 CpGs of TAPBP gene
identified in female offspring, only two overlapped
with those identified in the NEST cohort, of which
one (cg07500019) showed a positive association in
both ALSPAC and NEST. Of the 12 CpGs of the
TAPBP gene identified in males, none overlapped
with those identified in NEST. Also, none of the
CpGs of the TAPBP gene identified in ALSPAC
survived correction for multiple testing in female
or male offspring (Bonferroni correction for 227
tests – total CpGs that mapped to TAPBP gene –
P-value<0.00022).
Table 1. Selected baseline characteristics of study population
(n = 360) mother-offspring pairs), Newborn Epigenetics STudy
(NEST).
N % or Mean SD
Maternal age
<25 years 101 28.1
25–29 years 88 24.4
≥30 years 171 47.5
Maternal ethnicity




Less than high school 32 8.9
High school graduate 77 21.4
More than high school 251 69.7
Maternal cigarette smoking
Smoked during pregnancy 115 32.2
Did not smoke during pregnancy 242 67.8
Maternal BMI before pregnancy
<25kg/m2 173 48.1








Breastfeeding status in first 3 months
Never breastfed 69 19.2
Exclusively breastfed 56 15.6
Bottle and breastfed 109 30.3
Child BMI ≥85th percentile (age 4–5)
Not overweight/obese 160 67.2
Overweight/obese 78 32.8
Child BMI ≥95th percentile (age 4–5)
Not obese 194 81.5
Obese 44 18.5
Child Elevated BP (age 4–5)
No 137 85.6
Yes 23 14.4
Gestational age at delivery, months 360 38.3 2.3
Birth weight, grams 359 3108.2 667.5
BMI for age z score (age 4–5) 238 0.34 1.66
SBP percentile 160 57.98 27.65














































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Associations between differential methylation of
TAPBP and offspring cardiometabolic outcomes.
We evaluated whether methylation at CpGs identi-
fied in NEST near TAPBP were also associated with
offspring BMI z-score and systolic and diastolic BP
percentiles at 4–5 years of age. In female offspring,
we found evidence for association between two pre-
pregnancy obesity-related TAPBP CpG sites and
BMI z-score [cg23922433: β = 1.58, 95% CI: 0.73,
0.14; cg17621507: β = −1.18, 95% CI: −2.22, −0.16],
but not BP (Table 4). Another two TAPBP CpG sites
were associated with systolic BP percentile
[cg06230948: β = 9.54, 95% CI: 1.16, 17.93;
cg07955457: β = 23.49, 95% CI: 0.03, 46.96].
Among male offspring, one CpG site was associated
with higher systolic BP percentile [cg06230948:
β = 8.11, 95% CI: 0.29, 15.95] and one CpG site
was associated with lower diastolic BP percentile
[cg0378027: β = −23.70, 95% CI: −41.17, −6.23].
Assessment of functional importance
To further examine the functional significance of the
chromosome 6 genomic region containing pre-preg-
nancy obesity associated CpGs mapping to TAPBP
(28 CpG sites in female and 18 CpG sites in male
offspring), we used the UCSC Genome Browser to
visualize the ~700bp region of statistically significant
differential methylation identified by Illumina
HM450K Methylation arrays (Chr6: 28,911,468–
28,912,166, GRCh37/hg37; Supplemental Figure 1).
This region has 12 consecutive CpG sites with
p-values <5x10-5 and contains another 13 CpG
sites not included in the HM450K methylation
array. This region contains the noncoding RNA
LINC01556, and ENCODE data shows H3K27
methylation and partial overlap with two DNase I
hypersensitive sites that also contain binding sites for
more than 30 transcription factors, man of them
related to cardiometabolic risk. The total extent of
the DNase hypersensitive sites, transcription factor
binding regions, and histone H3K27 methylation is
1600bp, centered on the sequence region of differ-
ential methylation we found.
In order to determine the potential functional
significance of genes corresponding to differentially
methylated CpGs in males (31 significant genes) and
females (101 significant genes), we utilized the
Database of Genotypes and Phenotypes (dbGaP)
within the Disease/Drugs category of Enrichr
[23,24]. The three most significantly associated cate-
gories in males were narcolepsy, body weight, and
atherosclerosis, and in females, lymphocytes, ulcera-
tive colitis, and hypertension. However, after p-value
adjustment using the Benjamini-Hochberg method,
these results were not significant. As a comparative
measure, we also analyzed the 77 genes in the PACE
Figure 1. Manhattan plot for the associations between maternal pre-pregnancy obesity and offspring cord blood DNA methylation
among females (n = 187) after adjustment for estimated cell proportions. A total of 876 CpGs had an FDR-adjusted P-value <0.05































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































study [19] using dbGaP. The three most significantly
associated categories were insulin resistance, insulin,
and lipoproteins, however, after p-value adjustment,
these results were not significant. Given that our
analysis was sex-specific whereas the PACE study
was not, we note the limitation in our functional
comparisons between these studies. We do highlight
that indicators of cardiometabolic function (athero-
sclerosis, body weight, hypertension, and insulin
resistance) were identified as potential categories of
importance in both studies.
Discussion
To our knowledge, this is the first epigenome-wide
analysis to examine sex-specific associations
between maternal pre-pregnancy obesity, offspring
DNA methylation in cord blood, and offspring BMI
and BP. We identified multiple differentially methy-
lated CpG sites in umbilical cord blood among male
and female offspring of obese mothers compared
with non-obese mothers. A key finding of our study
was CpGs in or near the TAPBP gene were highly
associated with maternal obesity in both male and
female offspring. Specifically, we identified 74
maternal obesity-related CpG sites (57 CpGs in
female and 17 CpGs in male offspring) correspond-
ing to the TAPBP gene on chr6, located in the
group of genes involving the class 1 major histo-
compatibility complex. Associations were most
striking among female offspring, where methylation
differences of approximately 5% were detected in 21
consecutive CpG sites within a genomic region
spanning 700bp. The number and density of the
significant CpG sites of the TAPBP gene identified
were suggestive of a regulatory region warranting
further investigation. Therefore, the findings were
validated by pyrosequencing supporting the
hypothesis that the vulnerability of fetal homeosta-
sis differs by offspring sex. We further evaluated the
association between pre-pregnancy maternal obe-
sity-related CpG sites of TAPBP gene with offspring
cardiometabolic outcomes and found links to BMIz
and BP percentile in female offspring and systolic
and diastolic BP percentile in male offspring.
While many differentially methylated CpGs of
TAPBP gene were identified in relation to maternal
pre-pregnancy obesity in the NEST cohort, none
were replicated in the ALSPAC cohort. Reasons for
lack of replication are unclear, however, we note that
the prevalence and severity of pre-pregnancy mater-
nal obesity were very different between the two
cohorts – this might account for the discrepant find-
ings. Among women participating in NEST, the
mean BMI was 29 kg/m2, with an upper limit of
65 kg/m2, and the prevalence of pre-pregnancy
maternal obesity was 31%. ALSPAC cohort had
a lower mean BMI (22 kg/m2) and prevalence of
maternal obesity (5%). It also is possible that differ-
ences in confounding structures across the two
Figure 2. Manhattan plot for the associations between maternal pre-pregnancy obesity and offspring cord blood DNA methylation
among males (n = 173) after adjustment for estimated cell proportions. A total of 293 CpGs had an FDR-adjusted P-value <0.05
(solid horizontal blue line).
populations could account for our results not repli-
cating among the ALSPAC cohort. Differences in
ethnic distributions across the NEST and ALSPAC
cohorts may also contribute to the lack of replica-
tion – ALSPAC cohort comprised ~96% European
ethnicity, while NEST comprised 48% African
American and 44% European Americans. CpG sites
of TAPBP were also not identified in the larger
Pregnancy and Childhood Epigenetics (PACE) con-
sortium, a study of 23 independent cohorts [19]. The
PACE consortium conducted an epigenome-wide
DNA methylation study to identify CpG sites asso-
ciated with maternal BMI at the start of pregnancy,
where maternal overweight/obesity was defined as
BMI ≥ 25 kg/m2. Differential methylation at CpG
sites ofTAPBP genemay only be associated with pre-
pregnancy obesity among individuals with more
severe levels of obesity and in a sex-specific manner,
yet associations by sex were not examined. Lastly, we
did not identify any CpG sites that overlapped with
the 86 significant CpGs in the PACE consortium,
which is also likely due to the heterogeneity across
studies. Therefore, we suggest future studies replicate
our findings in cohorts with similar population
characteristics.
The significance of pre-pregnancy obesity asso-
ciated methylation levels observed in TAPBP gene
is unclear and requires gene- and network-specific
functional experiments to elucidate mechanisms
underlying these associations. However, hyper-
methylation of multiple CpG sites in TAPBP at
birth was recently shown to be associated with
increased risk of cardiometabolic endpoints (e.g.,
insulin sensitivity) among five-year old Australian
children [25]. Our data contributes to the novel
findings that hypermethylation of regulatory
sequences of TAPBP may be an important link
between maternal obesity and offspring cardiome-
tabolic dysfunction.
Sex-specific physiological and behavioral
responses to periconceptional obesity have been
repeatedly demonstrated in animal models (e.g.,
fed high-fat diets before conception) and observa-
tional studies of paternal obesity [26–28].
However, sex-specific human data linking mater-
nal obesity to periconceptional or prenatal obesity
epigenetic response are limited. Obesity in the
male or female parent at conception has been
associated with methylation differences at birth
of regulatory sequences of genes known to increase
obesity risk in human offspring, including those
targeting BDNF and IGF2, or identified from
methylation arrays [10,13,14,29,30].
In our sex-specific replication analysis of CpG
sites of the TAPBP gene andmaternal pre-pregnancy
obesity, initial statistically significant associations for
many CpG sites did not survive multiple compari-
sons correction. TAPBP encodes the transporter
associated with tapasin antigen processing (TAP)
binding protein, a transmembrane glycoprotein
that mediates the interaction between newly formed
MHC class 1 molecules and TAP, an interaction
essential for optimal peptide loading onto the
MHC and antigen display. [31]. While mechanisms
linking maternal obesity to sex-specific epigenetic
response are still unknown, higher methylation
levels of TAPBP such as those found in our study
might decrease tapasin via decreased transcriptional
activity, leading to impaired immune responses in
offspring. Decreased tapasin has been shown to
lower CD8 + T-cell responses in vitro [32–35].
Indeed, tapasin has also been associated with the
autoimmune disease rheumatoid arthritis [36–38],
and like obesity, this condition is also associated
with chronic inflammation. Both excess adipose tis-
sue and endothelial dysfunction are associated with
elevated levels of pro-inflammatory cytokines, such
as Interleukin-6 (IL-6) and Tumor Necrosis Factor-
alpha (TNF-α). In mice, tapasin is activated by the
cytokines IFN-γ and IFN-β, and to a lesser extent,
TNF-α [39]. Taken together, our results are consis-
tent with regulatory function for the identified
TAPBP CpG sites with further experimental studies
needed to confirm these findings. In addition to
further interrogating the 700bp chr6 region con-
tained within the HLA complex, evaluating whether
these differentially methylated genes serve as bio-
markers of immune dysfunction or as early indica-
tors of an already altered state of inflammation
might contribute to early obesity risk assessment
[40,41].
In addition to the TAPBP gene, multiple CpG sites
(ranging from 2–33 per gene) were also robustly
associated with maternal pre-pregnancy obesity in
female (e.g., GLIPR1L2, DDR1, and genomically-
imprinted WT1) and male (e.g., STMN1, CYP26C1,
TLR5, CMYA5, PIGZ, and genomically-imprinted
GFI1) offspring. These genes are posited to have
multiple annotated functions including cellular pro-
cesses such as cell proliferation, apoptosis, differen-
tiation and oncogenesis. Several also play major roles
in activation of immune response and inflammation.
DDR1 has been shown to contribute to the develop-
ment of Th17-dependent inflammatory diseases
[42,43]. Other genes, such as TLR5 and STMN1, are
involved in pathways linked to obesity and obesity-
related cancer [44]. TLR5 is a member of the toll-like
receptor family which has been linked to inflamma-
tion, obesity and metabolic dysfunction in both
humans and animal models [42,43,45–47]. Further,
the gut microbiome has been shown to be impacted
by TLR5 transcriptional activity in mice, which
resulted in metabolic syndrome – hyperlipidemia
hypertension, insulin resistance, and increased adip-
osity. STMN1, also known as stathmin 1, may have
a role in cell cycle progression and cell migration
[48,49]. Expression of STMN1 has been shown to
interact with BMI to influence colorectal cancer out-
comes [44]. Further work is warranted to examine the
potential mechanisms by which perturbation of these
genes might mediate the observed associations
between maternal obesity and offspring cardiometa-
bolic dysfunction outcomes such as blood pressure
and obesity.
This prospective study, conducted in an ethni-
cally and socioeconomically diverse population,
has several strengths that include: the use of an
established, highly reproducible methylation array;
a comprehensive comparison of both maternal and
childhood obesity by infant sex; and prospective
follow-up of offspring into early childhood at
4–5 years of age. Despite these strengths, study
limitations exist. First, the functional assessment
included a small number of genes as inputs in the
functional analysis tool, which limited the inter-
pretation of the findings from this analysis.
Second, pre-pregnancy obesity-associated CpG
methylation was measured in cord blood leuko-
cytes, yet the cell fractions driving these associa-
tions remain unknown, and should be investigated
in the future. Third, maternal pre-pregnancy
weight was based on self-reported data, which
may have resulted in exposure misclassification.
Fourth, with CpG methylation data available only
at birth, we cannot exclude the possibility that
postnatal modifications alter cardiometabolic sta-
tus in children. Finally, although paternal obesity
is correlated with maternal obesity, and paternal
obesity is associated with altered CpG methylation
in offspring [29,49], paternal anthropometric data
were available on only 92 of the 360 children with
DNA methylation measurements in NEST [50],
precluding paternal sex-specific analyses.
In summary, we found multiple CpG sites that
were differentially methylated at birth in relation
to maternal obesity, the most striking of which was
the TAPBP that was also associated with either
weight status or elevated blood pressure, depend-
ing on the sex of the offspring. While multiple
other CpG sites were also significantly associated
with maternal obesity, the TAPBP gene is asso-
ciated with immune-response and supports one
mechanism by which maternal obesity increases
the risk of offspring obesity and other cardiometa-
bolic phenotypes may be via epigenetic modifica-
tion of immune response before birth. Our data
highlight the importance of this region for future
interrogation to gain mechanistic insights linking




Study participants for the current analysis were
enrolled as part of the Newborn Epigenetics STudy
(NEST), a pre-birth cohort study designed to
improve our understanding of the role of environ-
mental influences on epigenetic responses and phe-
notypes in children. Between 2005 and 2009,
pregnant women receiving prenatal care at Duke
Maternal Fetal Medicine Clinic who intended to
use Duke Hospital for their obstetrics care were
enrolled using a recruitment protocol whose details
have been described previously [51,52]. Inclusion
criteria were age 18 years or older, English speaking,
and intent to use Duke University Medical Center
for obstetric care for the index pregnancy. From
these, women intending to move before the first
birthday of the offspring, relinquish custody of the
index child, or who had confirmed human
immunodeficiency virus (HIV) infection, were
excluded. A total of 1,101 eligible women were
approached, 895 (81%) consented and were enrolled,
and umbilical cord blood was successfully collected
from 741 infants. The current study is limited to the
360 mother-child pairs with pre-pregnancy BMI,
DNAm, and sex data; these pairs were comparable
to the remainder of the cohort, with respect to
maternal age at delivery, race/ethnicity, BMI, off-
spring weight, although these women had a higher
education than the remainder of the cohort
(p < 0.05). The study protocol was approved by the
Duke University and Durham Regional Hospital
Institutional Review Boards.
Data collection
Upon enrollment, participants completed a
questionnaire, which queried women on socio-
demographic, lifestyle and health characteristics.
At delivery, parturition data were obtained from
medical records, and infant cord blood specimens
were collected in EDTA-treated tubes, and subse-
quently centrifuged using standard protocols to
allow for collection of plasma and buffy coat for
DNA extraction (Qiagen, Valencia, CA, USA) and
stored at −80°C until required. Offspring were
followed annually and at each follow-up, care-
takers completed a caretaker-administered ques-
tionnaire regarding the feeding, sleep, and social
and physical activity habits of the child. Medical
records were also used to augment follow-up data.
Assessment of maternal body size
The enrollment questionnaire solicited informa-
tion on maternal pre-pregnancy anthropometric
measurements, including current height in meters
(m) and usual pre-pregnancy weight in kilograms
(kg) from which BMI was calculated and expressed
as kg/m2. In these analyses, participants were
defined as non-obese if their BMI was less than
30 kg/m2, and obese if their BMI was equal to or
greater than 30 kg/m2, according to the World
Health Organization classifications [53].
Assessment of childhood cardiometabolic
outcomes
Data to compute offspring BMI z-score and BP
percentiles were obtained from medical records
and directly measured height and weight. Sex-
specific body mass index (BMI) percentiles and
BMI z-score were computed based on the Centers
for Disease Control and Prevention protocols [54].
BP percentiles were calculated using the norms
recommended by the National Education Program
Working Group onHigh Blood Pressure in Children
and Adolescents [55].
Assessment of covariates
Women self-reported race/ethnicity, level of educa-
tion, and cigarette smoking status at enrollment. At
delivery, medical records were abstracted to obtain
maternal age at delivery and parturition data includ-
ing mode of delivery, infection in labor, gestational
age at birth, and infant birth weight and sex. In
addition to offspring weight and height, follow-up
questionnaires also queried mothers on breastfeed-
ing for each of the 12 months following delivery, and
breastfeeding duration was dichotomized at three
months. A priori, we considered infant sex as
a potential modifier of the association between
maternal obesity and offspring methylation as emer-
ging data suggest epigenetic perturbations may be
likely sex-specific [26,56]. Therefore, all CpG ana-
lyses were stratified by infant sex.
DNA methylation
Methods for DNAm analyses have been described
in detail elsewhere [57,58]. Briefly, cord blood
was collected at delivery and genomic DNA was
extracted from buffy coat specimen based on
standard precipitation procedure. Bisulfite con-
version was performed using the EZ-96 DNAm
kit (Zymo Research Corporation, Irvine, CA,
USA) according to manufacturer instructions.
Illumina’s GenomeStudio Methylation module
version 1.0 (Illumina, Inc.) was used to calculate
the methylation fractions as the beta-value [β =
M/(M + U + 100)], where M is the intensity of
the methylated allele and U is the intensity of the
unmethylated [59]. These beta values were log
transformed to obtain the log ratio (log[β/(1 –
β)]) and the detection p-value for each value,
which represents a statistical test for the differ-
ence between the signal for each CpG and back-
ground noise.
Data pre-preprocessing and normalization were
preformed using the minfi package in R [60]. Data
verification plots (q-q plots) were created for all
children and for each sex. A MethylSet object
containing only methylated and unmethylated sig-
nals was created using the preprocessRaw function
and beta-value densities were inspected to assess
sample quality. We performed quantile normaliza-
tion using preprocessQuantile function from the
minfi package. The normalization procedure was
applied to the methylated and unmethylated inten-
sities separately. Since probe types and probe
regions were confounded and DNA methylation
varies across regions we set the stratify options to
true. This normalization step also addressed out-
lier samples and removed poorly performing sam-
ples of both methylated and unmethylated
channels when small intensities were close to
zero. Batch normalization was preformed using
ComBat [61] function from sva R package using
plate as batch variable. A detection p-value is
returned for every genomic position in every sam-
ple. A small p-value indicates a good position and
significant above the background level. We
excluded probes with a detection p-value > 0.01
in more than 20% of the samples. Potential out-
liers were removed based on the values beyond the
lower and upper outer fences (values < 25th per-
centile minus 3 x interquartile range and values >
75th percentile + interquartile range) based on
PACE guidelines [19]. To pursue CpG methylation
marks responsive to pre-pregnancy obesity, we
also excluded probes that overlap with SNPs
using dropLociWithSnps function in minfi package
in R, as SNPs inside probe bodies or at nucleotide
extensions can alter data interpretation from
downstream analysis. The missing data were
imputed using champ.impute function from the
ChAMP [62] R package using combine method.
A total of 486,427 probes on the Illumina
Methylation 450k array comprising type I probes
(N = 135,476), type II probes (N = 350,036), con-
trol probes (N = 850) and SNP probes (N = 65)
were assessed. After removal of control probes,
probes with a detection p-value > 0.01 in more
than 20% of the samples, and those mapping to
SNPs, 422,916 CpGs remained from the robust
linear regression in 360 umbilical cord blood sam-
ples comprised of 173 males and 187 females.
DNA methylation validation
Targeted pyrosequencing among an independent
sample of NEST offspring, who were randomly
selected from obese and non-obese mothers, was
employed to validate two sequence regions. Assays
were designed to flank both CpG sites of the most
robust CpG methylation differences (p-values =
1e−12) in TAPBP and those of weaker association
(p-values = 1e−5) from the HM450K methylation
array in chromosome 6 (Chr6), referred to here as
region 1 and region 2. Primers targeting Chr6
maternal obesity region 1, (Hg38)
chr6:28,943,503–28,943,827, are Chr6Ob1F – 5ʹ
AGG AAA ATA GAA GAG GAA TTT GT-3ʹ;
Chr6Ob1R – 5ʹ [Btn]CAA AAA ATA CTA AAA
AAA AAA CC-3ʹ; Chr6Ob1S – 5ʹ AAT ATT TTA
TAT TGG TAG-3ʹ, primers to Chr6 maternal
obesity region 2–2, (Hg38) chr6:33,312,586–-
33,312,726, are Chr6Ob2-2F – 5ʹ cac CAG TGT
AAT AGG AGT TAT TTA ATT T-3ʹ; Chr6Ob2-
2R – 3ʹ [Btn]ctg aAA AAC AAA AAC TCT TAC
ACT C-3ʹ. Bases in lowercase for ChrOb2-2 pri-
mers are non-genomic sequences added in order
to optimize primer annealing temperatures.
Amplification conditions were as follows: 95⁰C –
5ʹ; 94⁰C – 20s, 55⁰C – 20s, 68⁰C – 40s, repeated
45X; 94⁰C – 3ʹ. For pyrosequencing, primer
Chr6Ob1S was used for Chr6Ob1 amplicons, pri-
mer Chr6Ob2-2F was used for Chr6Ob2-2 ampli-
cons. These assays were used to analyze 25ng
bisulfite converted leukocyte DNA of n = 44 off-
spring, 20 of them born to obese women.
Validation of DNAm quantitation used genomic
DNA controls with 0% and 100% methylation
(Qiagen, Inc.) mixed to generate methylation at
0%, 20%, 40%, 60%, 80%, and 100%.
Statistical analysis
Multivariable linear regression analyses were uti-
lized to estimate the association between pre-
pregnancy obesity (BMI≥30 vs. BMI<30 kg/m2)
and CpG site methylation. These analyses were
adjusted for maternal age, maternal cigarette
smoking during pregnancy, ethnicity/race, parity.
Cell type proportion were also adjusted for using
the estimateCellCounts function in the minfi
R package and the Reinius et al. reference dataset
[63,64]. The Houseman blood reference dataset
was utilized to estimate cell type proportion to
compare our findings to existing studies that also
used the Houseman reference (i.e., PACE consor-
tium). We also adjusted for multiple compari-
sons using a false discovery rate (FDR) [65]. As
a sensitivity analysis, we examined the sex-specific
associations between maternal pre-pregnancy obe-
sity and cell type estimates. The most robustly
associated CpG sites, based on number of CpG
sites with differential methylation and location
within the gene, were then examined for associa-
tions with offspring BMI z-score and BP percen-
tiles at age 4–5 years using multivariable linear
regression analyses adjusted for maternal age at
delivery, race/ethnicity, maternal pre-pregnancy
obesity, and smoking status during pregnancy.
DNA methylation replication
Replication was accomplished by analyzing HM450K
methylation array data using an identical analysis
plan and covariate adjustment set in 751 mother-
infant pairs (n = 367 mother-male pairs and n = 384
mother-female pairs) in the Avon Longitudinal Study
of Parents and Children (ALSPAC) cohort, despite
the lower prevalence of maternal obesity than NEST
participants (ALSPAC = 5% vs. NEST = 31%).
ALSPAC is a general population pregnancy cohort
that initially recruited 14,541 pregnancies with a due
date between April 1991 and December 1992 in
Avon, UK [66,67]. The study website contains details
of all the data that is available through a fully search-
able data dictionary (http://www.bris.ac.uk/alspac/
researchers/data-access/data-dictionary). Written in-
formed consent was obtained for all ALSPAC parti-
cipants and ethical approval was granted from the
ALSPAC Law and Ethics Committee and the local
Research Ethics Committees. Methylation data were
generated as part of the Accessible Resource for
Integrated Epigenomics Studies (ARIES) project as
described previously [68]. Data were normalized
using the functional normalization method within
the R package meffil [69]. CpG methylation was
also measured in mixed cord blood leukocytes.
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